UBS’s iPath Pure Beta Cocoa ETN CHOC Stock Holding History

UBS’s Portfolio CHOC Stock Details CHOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$102K	Buy	2,142 +1,483	+225%	+$68.3K	﹤0.01%	5976
2014 Q2	$30K	Buy	659 +394	+149%	+$17.2K	﹤0.01%	7582
2014 Q1	$11K	Buy	+265	New	+$11.2K	﹤0.01%	8867
2013 Q3	–	Sell	-850	Closed	-$27K	–	11328
2013 Q2	$27K	Buy	+850	New	+$28.8K	﹤0.01%	7546

Other funds holding CHOC

NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

CFA

Camarda Financial Advisors Fleming Island, Florida $190M AUM 48.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS's CHOC Position: Q3 2014 in Review

UBS increased its iPath Pure Beta Cocoa ETN (CHOC) stake by 225% in Q3 2014, buying an estimated $68.3K and bringing the position to 2,142 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #5976.

UBS first reported a position in CHOC in Q2 2013 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold CHOC as of Q3 2014.

UBS held 2,142 shares of iPath Pure Beta Cocoa ETN worth $102K as of Q3 2014.
UBS bought 1,483 iPath Pure Beta Cocoa ETN shares in Q3 2014, an estimated $68.3K.
iPath Pure Beta Cocoa ETN made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5976 holding.
UBS first reported a position in iPath Pure Beta Cocoa ETN in Q2 2013 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held iPath Pure Beta Cocoa ETN as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.